Romano Danesi

University of Milan — Italy

Medicine · Health Sciences

70h-index18.5kcitations663works6.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(92), Lung Cancer Treatments and Mutations(85), Cancer Genomics and Diagnostics(85), Cancer Treatment and Pharmacology(70), Pancreatic and Hepatic Oncology Research(64)

Publications663 total

Pharmacokinetic interactions and clinical implications of PPIs and CDKIs in breast cancer: a systematic review and meta-analysis
Systematic Reviews·2025Open Access
Liquid biopsy in Oncology: Results of a Delphi consensus study endorsed by the AIOM-SIAPEC/IAP-SIBioC-SIF Italian scientific societies
The Journal of Liquid Biopsy·2025Open Access
Italian expert consensus recommendations for the safe administration of high-dose methotrexate in children with cancer and for the use of glucarpidase to manage delayed methotrexate elimination and/or high-dose methotrexate-induced acute kidney injury
Current Research in Translational Medicine·2025Open Access
Weight-Based Pembrolizumab Dosing at 4 mg/kg Every 6 Weeks Leads to Exposures Below Approved Doses with Unestablished Efficacy: A Pharmacokinetic Model-Based Simulation Analysis
Targeted Oncology·2025Open Access
Nanoscale engagement of programmed death ligand 1 ( <scp>PD</scp> ‐ <scp>L1</scp> ) in membrane lipid raft domains of cancer cells
FEBS Journal·2025· 2 cited
Prevalence of hypertriglyceridemia and its association with extreme cardiovascular risk in patients with acute and chronic coronary syndrome enrolled in a cardiac rehabilitation program
International Journal of Cardiology·2025· 7 citedOpen Access
Vitamin D Levels in a Population of Healthy Subjects and its Association with Metabolic Derangement and Cardiac and Carotid Target Organ Damage
High Blood Pressure & Cardiovascular Prevention·2025
Immunocytokines in cancer treatment: A systematic review
Cancer Treatment Reviews·2025· 4 citedOpen Access
Clinical relevance and methodological approach for the assessment of drug–drug interactions in cancer patients: a position statement from the Italian Association of Medical Oncology (AIOM) and the Italian Society of Pharmacology (SIF)
ESMO Open·2025· 3 citedOpen Access
The Role of CPX-351 in the Acute Myeloid Leukemia Treatment Landscape: Mechanism of Action, Efficacy, and Safety
Drugs·2025· 5 citedOpen Access
Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan
The Oncologist·2025· 3 citedOpen Access
Real World Evidence in Oncology: An Italian examples-based Expert Opinion on Advancing Clinical and Regulatory Decision-Making
Annals of Research in Oncology·2025· 1 citedOpen Access
Covalent Bruton tyrosine kinase inhibitors across generations: A focus on zanubrutinib
Journal of Cellular and Molecular Medicine·2025· 4 citedOpen Access
Predicting Drug Dosage with Machine Learning: An Empirical Study Using Ceftaroline
Lecture notes in networks and systems·2025
Artificial intelligence-based pharmacological approach in non-small cell lung cancer in the precision medicine era
Cancer Treatment and Research Communications·2025Open Access
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients
Translational Oncology·2024· 5 citedOpen Access
Correction: Epigenetic patterns, accelerated biological aging, and enhanced epigenetic drift detected 6 months following COVID‑19 infection: insights from a genome‑wide DNA methylation study
Clinical Epigenetics·2024· 4 citedOpen Access
Targeting HER2 in breast cancer with brain metastases: A pharmacological point of view with special focus on the permeability of blood-brain barrier to targeted treatments
European Journal of Pharmacology·2024· 7 citedOpen Access
Epigenetic patterns, accelerated biological aging, and enhanced epigenetic drift detected 6 months following COVID-19 infection: insights from a genome-wide DNA methylation study
Clinical Epigenetics·2024· 15 citedOpen Access
Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer
Clinical Genitourinary Cancer·2024· 3 citedOpen Access
page 1 of 34Next →

Frequent Co-authors

Alfredo Falcone(16), Mario Del Tacca(16), Marzia Del Re(10), Elisa Giovannetti(9), Guido Bocci(9), Eleonora Rofi(7), Pierfranco Conté(7), Antonello Di Paolo(7), Godefridus J. Peters(5), Enrico Vasile(5), Valentina Mey(5), Sara Nannizzi(5), Douglas K. Price(5), Francesco Crea(5), Giacomo Allegrini(5), Gianluca Masi(4), Cinzia Orlandini(4), Alex Sparreboom(4), William D. Figg(4), Tristan M. Sissung(4)